CLAIMEL
Dead · Refused DEAD/APPLICATION/Refused/Dismissed or Invalidated
What this record means
The record shows that CLAIMEL is an abandoned application – the USPTO marked it “dead” after no Statement of Use was filed, with the abandonment notice dated September 8 2014 – and the owner listed is Glaxo Group Limited, a corporation organized in the United Kingdom. The filing covered only International Class 005, specifically “pharmaceutical preparations and substances” for a very wide range of medical conditions and vaccines, so a later use of the same word in the pharmaceutical field would be the closest record‑based concern. The record does not give Glaxo control over every possible use of the word CLAIMEL in other industries or contexts. Because the application was on the Principal Register and never reached registration, there is no supplemental‑register sequence to note. The latest meaningful event is the abandonment notice; no oppositions, cancellations or court actions appear in the history. I'd treat this as a modest concern if you plan a pharma‑related brand, but the risk drops sharply outside that sector.
Informational only - not legal advice.Mark Trademark
| Drawing type | 4 - STANDARD CHARACTER MARK |
| Filing basis | Intent-to-Use (§1(b)). |
| Status | Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page. |
Key dates
| Application filed | Jan 31, 2011 |
| Published for opposition | Jun 07, 2011 |
| Notice of Allowance | Aug 02, 2011 |
| Status date | Sep 08, 2014 |
Goods & services
Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological,gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Owner & representation
| Owner | Glaxo Group Limited |
| Address | 980 Great West Road, Brentford, Middlesex UNITED KINGDOM TW89GS |
| Entity | CORPORATION - organized in UNITED KINGDOM |
| Attorney of record | Christopher M. Hanes |
| Correspondent | Christopher M. Hanes |
| Attorney email | t********@*****.com |
| Correspondent email | t********@*****.com |
| Correspondent phone | 9********3 |
| Correspondent address | Research Triangle Park, NORTH |